WHWK Whitehawk Therapeutics, Inc.

XNAS 3.13 Delayed
Find condors

Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.

WHWK $3.13 —
Key stats
$3.13
52-Week Range
$1.97 – $5.50
YTD
+28.48%
Straddle Price
$1.98
P/C Vol Ratio
0.12
Market Cap
$0.2B
Open
$3.14
Day Range
$2.97 – $3.21
Volume
309,308
Prev Close
$3.13
Fair Value
MODEL: LONG

A blended fair-value estimate combining up to six valuation methods. Each method is weighted by how well it fits the company — DCF down-weights for unprofitable names; DDM only fires for steady dividend payers; comparables down-weight when peer multiples disagree.

  • DCF (quality-aware) — projects free cash flow with a horizon that scales to business quality. True compounders (quality 6/6) get 10 years explicit + 10 years fade before terminal; cyclical/struggling names (quality 0-1) get a 5-year terminal cliff. Quality is scored from ROE, gross margin, growth, FCF margin, debt load, and FCF consistency — the same factors that drive market premium for compounders.
  • Market-Implied Growth (in Model Inputs) — reverse-DCF that answers "what growth rate is the market pricing in?". Lets you sanity-check the deviation: if implied growth is plausible for the business, the model's bearish flag may be wrong; if implausible, the market may be over-extrapolating.
  • DDM (Gordon Growth Dividend Model) — values the stream of future dividends. Only used when trailing yield ≥ 2% and dividend payments are stable — below that the dividend is a token payout and Gordon (which values only the dividend stream) systematically underprices growth names, so those route to DCF + comparables + market anchor instead.
  • P/E, EV/EBITDA, P/B, P/S — applies the peer-group median multiple to this company's per-share metric. Peers come from the same set as the "Related symbols" card. Earnings/sales metrics are forward-tilted by the company's recent revenue growth (capped at 25%) so they're comparable to peers' growth-embedded multiples — mimics how analysts use NTM rather than TTM. Per-multiple weights are biased by company quality (e.g. P/B down-weighted for asset-light tech).
  • Market Anchor (SMA50) — the 50-day moving average, weighted by recent trading-range stability (tighter Bollinger bands → higher weight). Captures information fundamentals miss (forward consensus, sentiment, supply/demand) — but only when recent trading is steady enough that the market has converged on a view. During wild breakouts or breakdowns the anchor's weight collapses.
  • Options Expected (B-L 30d) — the risk-neutral expected stock price at 30-day options expiration, derived from the full implied-volatility surface via Breeden-Litzenberger (second derivative of call price wrt strike → implied PDF, then E[S_T]). Forward-looking, captures all options-implied information (smile, skew, term structure) in one number. Weighted by chain liquidity. SP500-only at present (pre-computed daily). Backtest evidence: adds modest alpha across most bucket × holding combos.
  • Blended value — weighted average. Confidence reflects how many methods fired and how tight peer dispersion is.
  • Deviation pill — green when blended FV ≥ 10% above current price (undervalued); red when ≥ 10% below; grey otherwise.
10-yr Treasury (rf)5.12%
Beta vs SPY1.27
Cost of Equity (CAPM)12.12% (VRP-adj)
WACC12.24%
Volatility Risk Premium+138.2pp (IV − HV30), ERP adj +50bps
Effective Tax Rate21.0%
Rev. Growth (YoY, DCF input)+3.0%
DCF Horizon5 years explicit + fade
Forward Tilt (NTM/TTM)×1.03 (applied to P/E, EV/EBITDA, P/S)
Free Cash Flow (TTM)$-0.1B
Return on Equity (TTM)-51.1%
Book / Price66.1% — banking bias active (P/B is primary)
Debt / Equity0.00
Quality Score1/6 — cyclical/struggling (5y DCF)
SMA 50$3.45 (Market Anchor value)
SMA 20 / Bollinger Mid$3.17
Bollinger Width / SMA2014.0% (drives anchor stability)
Net Debt$-0.1B
Market Cap$0B
Peers used for multiples: CYRX, KIDS, MYGN, PCRX, XNCR (filtered from 8 ETF-co-members; sector bias active)
60-Day Conviction
95%
20-Day Fair Value
≈ by Dec 18, 2026
$3.15
α +0.5% rank 68%
conviction
57%
40-Day Fair Value
≈ by Jan 18, 2027
$3.19
α +2.0% rank 71%
conviction
90%
60-Day Fair Value
≈ by Feb 16, 2027
$3.26
α +4.1% rank 66%
conviction
95%
MethodImplied PriceWeightDetail
DCF n/a 0%
DDM (Gordon) n/a 0%
Peer P/E n/a 0%
Peer EV/EBITDA n/a 0%
Peer P/B $4.28 20% median 2.1× · 5 peers
Peer P/S n/a 0% median 3.1× · 5 peers
Market Anchor (SMA50) $3.45 80% stability 80% (BB-width)
Options Expected (B-L 30d) n/a 0%
As of 2026-11-19 · updated
About
Industry (SIC)
PHARMACEUTICAL PREPARATIONS (2834) · industry map
Exchange
XNAS
Market Cap
$0.2B
Employees
23
List Date
2021-08-27
CIK
0001422142
Last Earnings
Nov 9 after close · −4.3% vs ±61.3% expected
Headquarters
Morristown, NJ
Homepage
https://www.whitehawktx.com

Whitehawk Therapeutics Inc is an oncology therapeutics company applying technologies to tumor biology to develop cancer treatments. Its portfolio includes three antibody-drug conjugate (ADC) candidates designed to address limitations of earlier therapies for patients with difficult-to-treat cancers. The company generates revenue from the sale of its products.

Summary
—
composite
—
No summary data available for this symbol yet.

Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.

Chart

Markers: Click a marker type to show or hide it. Earnings turn amber when the stock moved more than options implied; hollow markers are still to come, or insider trades under a 10b5-1 plan. Intraday times are New York time; shaded bars are pre-market and after-hours.

Seasonality
Month'25'26Avg
Jan--10.66%10.66%
Feb--21.87%21.87%
Mar-11.88%6.48%-2.70%
Apr-12.94%13.28%0.17%
May1.20%18.30%9.75%
Jun7.47%2.00%4.73%
Jul-5.91%-12.99%-9.45%
Aug3.74%14.65%9.20%
Sep4.40%-18.79%-7.19%
Oct25.65%-13.83%5.91%
Nov5.41%0.32%*2.87%
Dec7.08%--7.08%
Total20.59%37.46%29.03%
* Only 2 year(s) of data available.
Technical Indicators

Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.

Trend Indicators
  • SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
  • EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
  • MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
  • ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
  • +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
  • RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
  • Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
  • Williams %R — inverted scale: <−80 oversold, >−20 overbought.

Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.

Volume & Volatility
  • Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
  • OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
  • Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
  • ATR / True Range — average daily $ move; sizing and stop-loss reference.
  • HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.

Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →

Trend Indicators

SMA 20: $3.16
SMA 50: $3.44
SMA 200: $3.86
Current: $3.13
EMA 12: $3.12
EMA 26: $3.22
MACD: -0.0936 | Signal: 0.0218
BEARISH
ADX (14): 18.74
RANGE
+DI: 15.58
−DI: 20.81

Momentum Oscillators

RSI (14): 45.89
NEUTRAL
Stoch %K: 40.32
Stoch %D: 31.36
Williams %R: -53.68

Volume & Volatility

BB Upper: $3.38
BB Lower: $2.94
NEUTRAL
OBV: 106,826,749
Vol SMA 20: 379,797
Vol ROC: -56.18%
ATR: $0.21
True Range: $0.23
HV 20: 55.2%
HV 30: 63.6%
HV 60: 52.6%

Data Summary

Data Points: 421
Last Updated:
Date Range: 2025-03-19T00:00:00 – 2026-11-18T00:00:00
AI Analysis

Click Frenzy-Pro™ for an AI analysis of this ticker.

Analysis includes technical indicators, news sentiment, risk assessment, and specific price levels to watch.

Earnings History
7 of 7 under expected move
Avg Expected Move
100.03%
Avg Actual Move
1.93%
Each row pairs the pre-earnings straddle-implied expected move with the realized close-to-close move. Sorted oldest first.
Earnings Date Timing Expected Move Actual Move Ratio Outcome
2025-05-08 After-Close 74.70% 3.66% 0.05x Within
2025-08-07 After-Close 97.38% 1.74% 0.02x Within
2025-11-06 After-Close 94.05% 1.43% 0.02x Within
2026-03-12 After-Close 75.00% 0.26% 0.00x Within
2026-05-07 After-Close 252.54% 0.76% 0.00x Within
2026-08-06 After-Close 45.21% 1.28% 0.03x Within
2026-11-09 After-Close 61.34% 4.35% 0.07x Within

Earnings calendar: this week’s reports with expected vs actual moves →

WHWK Options Activity & IV Rank

Volatility Metrics

Current IV: —
7-DTE IV: —
Expected Move: $1.98
7-DTE Move: $1.93
Days to Exp: 29 (2026-12-18)

Options Flow · All expiries

Call Volume: 17
Put Volume: 2
P/C Volume: 0.118
BULLISH
Call OI: 23
Put OI: 6
P/C OI: 0.261
Total OI: 29

ATM Options Pricing

ATM Call: $1.60
ATM Put: $0.38
Call %: 51.0%
Put %: 12.0%

Chain Summary

Chain Volume: 19
Chain OI: 29
Last Updated: 11/19/2026

WHWK Implied Volatility

Loading implied volatility…

The 30-day IV is the at-the-money implied volatility of options 30 days out, the blue line. The band is its 20-session average, 2 standard deviations either side. Realized volatility is how much WHWK actually moved over the last 20 sessions, from closing prices, on the same yearly scale. Without earnings takes each earnings report out of the 30-day IV, sized from what options paid for past reports, so it shows whether options are expensive or cheap apart from the report. Click a name above the chart to show or hide it.

Spread Scanner

Each spread is ranked by a composite score built in three stages. Full documentation →

Stage 1 — Base Score

score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Calendars: the long leg is valued at the short leg’s expiration (Black-Scholes at its current IV) across the range of prices the short leg’s IV implies, giving the best-case profit (R/R = that over the debit) and P(profit).

Stage 2 — Skew Adjustment (±25% cap)

RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.

Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
  • RSI <40 bullish / >60 bearish
  • MACD crossover + histogram trend
  • Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
  • Stochastic %K <20 / >80
  • Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
  • Blended ATR + straddle expected-move penalty
  • Bollinger Band signal (+ counter-trend penalty)
  • BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
  • IV rank ≥ 75 → strong boost for credit spreads
  • IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
  • Min open interest across all legs
  • OI < 100 → −0.10 · OI < 500 → −0.05

score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →

Scanning bull put, bear call, iron condor and calendar spreads…

Dealer Positioning
LOW γ vs HISTORY

Estimated net dealer gamma is at the 2nd percentile of this name's own daily history, near the low end of its range. This describes current positioning; it is not a forecast or a trading signal.

Gamma percentile
2%
vs own history
GEX tilt
-0.54
OI-weighted, today
Vanna tilt
-0.05
δ-sensitivity to IV
Charm tilt
-1.00
δ-decay vs time
Charm tilt -1.00: the estimated dealer exposure leans negative, so the modeled hedge would shift noticeably as time passes and options approach expiry.

Net dealer gamma is an estimate of the aggregate gamma held by options market makers across this name's option chain, weighted by open interest. Dealer positions aren't public, so it uses a standard simplifying assumption: dealers are treated as long the calls and short the puts that are open. Actual dealer books can differ.

Gamma percentile ranks today's estimate against this name's own daily history, from 0% (the lowest reading on record) to 100% (the highest). Raw gamma scales with how much open interest a chain carries, so it isn't comparable across names; the percentile is. The badge marks the bottom 20% as low and the top 20% as high.

Tilts run from −1 to +1 and show how lopsided the estimated dealer exposure is. GEX tilt compares call gamma with put gamma. Vanna tilt describes how the hedge would shift if implied volatility changed, and charm tilt how it would shift with the passage of time.

This card describes estimated positioning and where it sits historically. It is not a forecast of price direction or volatility and not a trading signal. Market-wide view: Dealer positioning screener.

· 3 ATM contracts, 0k total OI
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Metric:
Put vs ATM
IV(put wing) − IV(ATM), in vol points

How much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.

  • Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
  • Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
  • Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
  • Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each side

Which side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.

  • Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
  • Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
  • Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
  • Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Call vs ATM
IV(call wing) − IV(ATM), in vol points

The same measure on the upside: how the OTM call is priced against the at-the-money strike.

  • Negative (typical) — calls trade below ATM for most stocks and indices, so the sign alone says little.
  • Percentile vs own history: high = upside calls unusually rich for this name (squeezes, takeover talk, commodity supply scares); low = calls cheaper than usual.
Reading them together

Put or call vs ATM tells you how expensive that tail is. Risk Reversal tells you which side is favored. Combined:

  • High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
  • Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
  • Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d put —
— pts EXTREME
No data
30 DTE / 10d put —
— pts EXTREME
No data

Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.

Volatility Surface

Loading the implied volatility surface…

Volatility Smile

Loading the implied volatility smile…

IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)$1.98Nov 19
Beta Analysis

Risk Metrics

Beta: 1.4617
Alpha: 50.29%
Correlation: 0.2944
R-Squared: 8.7%
Stock Volatility: 68.8%
Market Volatility: 13.9%

Analysis Details

Benchmark: SPY
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
Beta & Alpha Over Time
Notable investors who own WHWK
4 of 37 tracked investors
InvestorValueShare of their portfolioRankQ/Q sharesSource
Renaissance Technologies Hedge fund
Jim Simons
$2.5M
0.00%
#1832 of 3151+60.4%13F
Millennium Management Hedge fund
Izzy Englander
$1.7M
0.00%
#2647 of 3716+22.8%13F
Point72 Hedge fund
Steve Cohen
$262K
0.00%
#1739 of 1945+103.8%13F
Citadel Hedge fund
Ken Griffin
$138K
0.00%
#5645 of 6285-67.2%13F

Hedge funds, activists, holding companies and family offices we track, from their latest 13F (quarter-end value) and Form 4 filings in the last 3 years. Family offices · all institutions

WHWK Institutional Ownership (13F)

Filings for 2026-09-30
Diluted shares outstanding: 78,829,069 (as of 2026-09-30)

Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.

  • Shares — long equity positions in this name, aggregated across share classes.
  • Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
  • % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
  • Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.

Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.

92 filers45,712,199 shares$199.18M value57.99% of float
# Filer Shares Value % of Total % of Float Period
1 Yu Fan 4,861,314 $22.26M 11.18% 6.17% 2026-06-30
2 ACUTA CAPITAL PARTNERS, LLC 4,685,912 $21.46M 10.78% 5.94% 2026-06-30
3 QVT Financial LP 4,615,709 $21.14M 10.61% 5.86% 2026-06-30
4 MONTANOVA CAPITAL, LLC 4,300,000 $19.69M 9.89% 5.45% 2026-06-30
5 ORBIMED ADVISORS LLC 3,934,296 $18.02M 9.05% 4.99% 2026-06-30
6 Avoro Capital Advisors LLC 2,849,402 $13.05M 6.55% 3.61% 2026-06-30
7 KVP Capital Advisors, LP 2,165,997 $9.92M 4.98% 2.75% 2026-06-30
8 BlackRock, Inc. Custodian 2,589,723 $9.74M 4.89% 3.29% 2026-09-30
9 Siren, L.L.C. 2,337,102 $8.79M 4.41% 2.96% 2026-09-30
10 Vanguard Capital Management LLC 1,465,827 $5.51M 2.77% 1.86% 2026-09-30
11 ACORN CAPITAL ADVISORS, LLC 1,139,363 $5.22M 2.62% 1.45% 2026-06-30
12 ADAR1 Capital Management, LLC 1,341,394 $5.04M 2.53% 1.70% 2026-09-30
13 STEMPOINT CAPITAL LP 1,021,037 $4.68M 2.35% 1.30% 2026-06-30
14 Geode Capital Management, LLC Custodian 1,055,562 $3.97M 1.99% 1.34% 2026-09-30
15 Ally Bridge Group (NY) LLC 817,939 $3.75M 1.88% 1.04% 2026-06-30
16 RENAISSANCE TECHNOLOGIES LLC 663,922 $2.50M 1.25% 0.84% 2026-09-30
17 State Street Corp 591,672 $2.22M 1.12% 0.75% 2026-09-30
18 Woodline Partners LP 436,614 $2.00M 1.00% 0.55% 2026-06-30
19 Millennium Management LLC Custodian 380,406 $1.74M 0.87% 0.48% 2026-06-30
20 ACADIAN ASSET MANAGEMENT LLC 436,226 $1.64M 0.82% 0.55% 2026-09-30
21 Eversept Partners, LP 303,306 $1.39M 0.70% 0.38% 2026-06-30
22 Verdad Advisers, LP 301,483 $1.38M 0.69% 0.38% 2026-06-30
23 Two Sigma Investments, LP Custodian 296,612 $1.36M 0.68% 0.38% 2026-06-30
24 Balyasny Asset Management L.P. 288,117 $1.32M 0.66% 0.37% 2026-06-30
25 Northern Trust Corp Custodian 264,689 $1.21M 0.61% 0.34% 2026-06-30
# Filer Notional Value % of Total Period
1 filers$376 notional
# Filer Notional Value % of Total Period
1 Simplex Trading, LLC Custodian $376 100.00% 2026-09-30

WHWK Insider Trading (Form 4)

Latest: 2026-09-18
Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
Filed Reporter Role Action Shares Avg Price Net $ Link
2026-09-18 David James Lennon CHIEF EXECUTIVE OFFICER Grant (A) +387,914 opt — EDGAR
2026-09-18 Scott M. Giacobello CHIEF FINANCIAL OFFICER Grant (A) +236,952 RSU — EDGAR
2026-09-18 Bryan Ball See remarks Grant (A) +183,266 opt — EDGAR
2026-09-18 Margaret Dugan Chief Medical Officer Grant (A) +162,500 opt — EDGAR
2026-09-18 David Dornan Chief Scientific Officer Grant (A) +171,774 opt — EDGAR
2026-09-15 Margaret Dugan Chief Medical Officer Grant (A) +162,500 RSU — EDGAR
2026-09-15 Bryan Ball See remarks Grant (A) +183,266 RSU — EDGAR
2026-09-15 Scott M. Giacobello CHIEF FINANCIAL OFFICER Grant (A) +236,952 RSU — EDGAR
2026-09-15 David Dornan Chief Scientific Officer Grant (A) +171,774 opt — EDGAR
2026-09-15 David James Lennon CHIEF EXECUTIVE OFFICER Grant (A) +387,914 opt — EDGAR
2026-09-11 Vijay K Iyengar Director Grant (A) +76,080 opt — EDGAR
2026-07-30 Anupam Dalal Director Award (A) +1,275,510 $3.92 $5.00M EDGAR
2026-06-15 Neil Desai Director Grant (A) +38,040 opt — EDGAR
2026-06-15 Richard E Maroun Director Grant (A) +38,040 opt — EDGAR
2026-06-15 Avoro Capital Advisors LLC Director Grant (A) +38,040 opt — EDGAR
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.

WHWK Insider Holdings

6 insiders · @ $3.13
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
# Insider Role Shares Disclosed Exposure Lifetime OM Net Filings Last Filed
1 Anupam Dalal Director 4,687,042 $14.67M $0 2 2026-07-30
2 Caley Castelein Director 2,440,794 $7.64M $0 3 2026-06-15
3 David James Lennon CHIEF EXECUTIVE OFFICER 569,643 $1.78M -$1.06M 8 2026-09-18
4 Bryan Ball See remarks 448,126 $1.40M -$635.1K 8 2026-09-18
5 Scott M. Giacobello CHIEF FINANCIAL OFFICER 333,489 $1.04M -$890.6K 7 2026-09-18
6 Margaret Dugan Chief Medical Officer 19,132 $59.9K $0 5 2026-09-18
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.

WHWK Board & Officers

As of SEC filings through Sep 18, 2026

Directors 12

Officers 5

10% owners 3

Changes in the last 10 years (63)
Sep 9, 2026Vijay K Iyengar became a director
May 18, 2026Bryan Ball listed as Chief Technical Operations Officer (previously Chief Technical Operations Officer and SVP, Manufacturing Operations) in SEC filings
Dec 1, 2025Margaret Dugan became Chief Medical Officer
Jun 17, 2025Neil Desai no longer listed as Executive Chairman in SEC filings
Feb 18, 2025David Dornan became Chief Scientific Officer
Dec 19, 2024Baiteng Zhao became a director
Apr 23, 2024Bryan Ball became Chief Technical Operations Officer and SVP, Manufacturing Operations
Oct 2, 2023David James Lennon became a director
Oct 2, 2023David James Lennon became Chief Executive Officer
Jul 6, 2023Neil Desai no longer listed as a 10% owner in SEC filings
Jun 20, 2023Behzad Aghazadeh first listed as a 10% owner in an SEC filing
Jun 20, 2023Avoro Ventures LLC first listed as a 10% owner in an SEC filing
Jun 20, 2023Avoro Capital Advisors LLC first listed as a 10% owner in an SEC filing
Mar 27, 2023Mohammad Hirmand became a director
Mar 2, 2023The company announced the departure of Brendan Delaney from the board in an SEC filing
Mar 2, 2023The company announced the departure of Brendan Delaney as President and Chief Executive Officer in an SEC filing
Jan 4, 2023Neil Desai listed as Executive Chairman (previously President and Chief Executive Officer) in SEC filings
Jan 4, 2023Brendan Delaney listed as President and Chief Executive Officer (previously Chief Operating Officer) in SEC filings
Jan 4, 2023Brendan Delaney first listed as a director in an SEC filing
Jun 17, 2022Avoro Ventures LLC first listed as a director in an SEC filing
Not reported recently (20)
  • Karin M. Hehenberger · Last reported as a director in an SEC filing dated Jun 14, 2024
  • Lorettta M Itri · Last reported as Chief Medical Officer in an SEC filing dated Mar 4, 2024
  • Lance E Thibault · Last reported as Chief Financial Officer in an SEC filing dated Aug 31, 2021
  • Pravin Dugel · Last reported as a director in an SEC filing dated Jul 2, 2021
  • Steven Prelack · Last reported as a director in an SEC filing dated Jul 2, 2021
  • Cheryl Cohen · Last reported as a director in an SEC filing dated Jul 2, 2021
  • OrbiMed Capital GP V LLC · Last reported as a 10% owner in an SEC filing dated Dec 10, 2020
  • Orbimed Advisors LLC · Last reported as a 10% owner in an SEC filing dated Dec 10, 2020
  • Kevin G. Peters · Last reported as Chief Scientific Officer in an SEC filing dated Mar 18, 2020
  • Joseph H. Gardner · Last reported as a director in an SEC filing dated Mar 18, 2020
  • Regina Marek · Last reported as Vice President of Finance in an SEC filing dated Mar 18, 2020
  • Chau Quang Khuong · Last reported as a director in an SEC filing dated Jun 19, 2019
  • Muneer A Satter · Last reported as a director in an SEC filing dated Jun 19, 2019
  • Michael W Rogers · Last reported as Chief Financial Officer in an SEC filing dated May 16, 2019
  • Stephen J Hoffman · Last reported as Chief Executive Officer in an SEC filing dated May 16, 2019
  • Steve Pakola · Last reported as Chief Medical Officer in an SEC filing dated Feb 20, 2019
  • Dhaval Desai · Last reported as Chief Strategy Officer in an SEC filing dated May 21, 2018
  • Samuel D Isaly · Last reported as a director in an SEC filing dated Mar 17, 2017
  • Paul M Weiss · Last reported as a director in an SEC filing dated Mar 17, 2017
  • James B Murphy · Last reported as an officer in an SEC filing dated Mar 17, 2017
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.

WHWK Proposed Insider Sales (Form 144)

Latest: 2026-04-15
Last 30d: 0 filings  ·  Last 90d: 0 filings

What is Form 144? A notice of intent to sell restricted or control stock under Rule 144. Affiliates (officers, directors, 10%+ owners) and holders of restricted shares must file Form 144 when planning to sell more than 5,000 shares or $50,000 in any 3-month rolling window.

How it relates to Form 4: Form 144 is filed before the trade (up to 90 days in advance); Form 4 is filed within 2 business days after the trade executes. Not every Form 144 results in a sale — the filer may cancel or delay. Look for the corresponding Form 4 on the Insider Activity card to confirm a sale actually happened.

10b5-1 plans: Trades made under a pre-scheduled Rule 10b5-1 plan are not discretionary — they execute automatically on dates set months earlier, regardless of news. High 10b5-1 percentages mean less per-filing signal value, though cumulative selling volume still matters.

"Notice value": Aggregate market value the filer wrote into the Form 144 — i.e. the size of the planned sale, not necessarily the executed dollars. An amended notice (Form 144/A) replaces the original it amends, and cancelled notices are dropped, so neither is double-counted above. A filed value that is clearly inconsistent with the share count at the stock's price (a filer typo) shows as a dash and is left out of the totals.

Source & freshness: Sourced from public Form 144 filings. Refreshed daily; new filings typically appear here the morning after they are filed.

Filed Filer Role Shares Notice Value Planned Sale Broker Plan Link
2026-04-15 Giacobello Scott M. Officer 233,766 $900.0K 2026-04-15 E-TRADE Financial Corporation — EDGAR
2026-04-09 Lennon David James Officer, Director 4,364 $14.8K 2026-04-09 E-TRADE Financial Corporation — EDGAR
2026-04-09 BALL BRYAN Officer 196,969 $650.0K 2026-04-09 E-TRADE Financial Corporation — EDGAR
2026-04-02 Lennon David James Officer, Director 297,421 $1.03M 2026-04-02 E-TRADE Financial Corporation — EDGAR
2025-03-03 Lennon David James Officer, Director 5,690 $13.4K 2025-03-03 E-TRADE Financial Corporation — EDGAR
2025-03-03 Giacobello Scott M. Officer 2,806 $6.6K 2025-03-03 E-TRADE Financial Corporation — EDGAR
2025-03-03 BALL BRYAN Officer 2,147 $5.0K 2025-03-03 E-TRADE Financial Corporation — EDGAR
2024-10-03 Lennon David James Officer, Director 9,689 $18.8K 2024-10-03 E-TRADE Financial Corporation — EDGAR
2024-09-03 Desai Neil Officer 120,000 $214.4K 2024-09-03 THE CHARLES SCHWAB CORPORATION 10b5-1 EDGAR
2024-06-03 Desai Neil Officer 120,000 $220.0K 2024-06-03 THE CHARLES SCHWAB CORPORATION 10b5-1 EDGAR
Notice value is the aggregate market value the filer states they intend to sell — not a confirmed transaction. Compare to Insider Activity (Form 4) to see which planned sales actually executed. Market-wide feed: Planned sales (Form 144).
Recent SEC Filings
Latest: 2026-11-09
Current reports — material events the company must disclose within 4 business days (earnings releases, M&A, executive changes, etc.).
Filing Date Event Link
2026-11-09 Earnings results EDGAR
2026-09-10 Director or officer change EDGAR
2026-08-06 Earnings results EDGAR
2026-06-12 Shareholder vote results EDGAR
Annual report — audited financial statements, MD&A, risk factors. Filed 60–90 days after fiscal year-end.
Filing Date Accession Link
Quarterly report — unaudited financials and MD&A. Filed 40–45 days after each of the first three fiscal quarters.
Filing Date Accession Link
2026-11-09 0001193125-26-453576 EDGAR
2026-08-06 0001193125-26-337933 EDGAR
ETF Holders
26 ETFs hold WHWK
25 shown · $10.55M total exposure · 0.00% AUM-weighted avg weight
# ETF Provider Weight $ Exposure ETF AUM As Of
1 IWM iShares Russell 2000 ETF iShares (BlackRock) 0.00% $3.2M $75.0B 2026-11-17
2 VTI Vanguard Morningstar Total Stock Market ETF Vanguard 0.00% $2.3M — 2026-10-31
3 VXF Vanguard Extended Market ETF Vanguard 0.00% $1.8M — 2026-10-31
4 IWN iShares Russell 2000 Value ETF iShares (BlackRock) 0.01% $1.2M $13.6B 2026-11-17
5 VTWO Vanguard Russell 2000 ETF Vanguard 0.00% $830,943 — 2026-10-31
6 IWC iShares Micro-Cap ETF iShares (BlackRock) 0.04% $415,209 $1.2B 2026-11-17
7 AVSC Avantis U.S. Small Cap Equity ETF Avantis 0.01% $193,175 $3.1B 2026-11-17
8 GSSC Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF Goldman 0.02% $166,037 $1.0B 2026-11-17
9 VTWV Vanguard Russell 2000 Value ETF Vanguard 0.01% $127,782 — 2026-10-31
10 QQQS Invesco NASDAQ Future Gen 200 ETF Invesco 0.42% $82,107 — 2026-11-17
11 RSSL Global X Russell 2000 ETF Global X 0.01% $64,024 — 2026-11-18
12 DFAT Dimensional US Targeted Value ETF Dimensional 0.00% $31,616 — 2026-11-17
13 DFSV Dimensional US Small Cap Value ETF Dimensional 0.00% $31,231 — 2026-11-17
14 DFMC Dimensional US Micro Cap ETF Dimensional 0.00% $14,011 — 2026-11-17
15 VTHR Vanguard Russell 3000 ETF Vanguard 0.00% $11,045 — 2026-10-31
16 DFAU Dimensional US Core Equity Market ETF Dimensional 0.00% $10,965 $12.5B 2026-11-17
17 DXUV Dimensional US Vector Equity ETF Dimensional 0.00% $10,256 — 2026-11-17
18 DFSU Dimensional US Sustainability Core 1 ETF Dimensional 0.00% $9,745 $2.3B 2026-11-17
19 DFAS Dimensional US Small Cap ETF Dimensional 0.00% $9,305 — 2026-11-17
20 ITWO ProShares Russell 2000 High Income ETF ProShares 0.00% $7,668 — 2026-11-18
21 URTY ProShares UltraPro Russell2000 ProShares 0.00% $5,362 — 2026-11-18
22 AVTM Avantis Total Equity Markets ETF Avantis 0.00% $3,862 $739.5M 2026-11-17
23 UWM ProShares Ultra Russell2000 ProShares 0.00% $3,546 — 2026-11-18
24 FEAC Fidelity Enhanced U.S. All-Cap Equity ETF Fidelity 0.01% $1,722 $16.5M 2026-11-17
25 HDG ProShares Hedge Replication ETF ProShares 0.00% $169 — 2026-11-18
Fundamentals

Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.

Metrics
  • Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
  • Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
  • Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
  • Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
  • Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
  • YoY growth — compare to the same quarter a year earlier to remove seasonality.
  • Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
  • Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.

TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.

Trailing P/E
—
TTM Diluted EPS
$-1.09
TTM Revenue
$0.00
TTM Net Income
$-83.42M
TTM Op. Cash Flow
$-73.64M
Quarterly figures (7 quarters)
QuarterPeriod EndRevenueNet IncomeDiluted EPSOp. Cash Flow
Q3 '262026-09-30$0.00$-21.21M$-0.23$-19.67M
Q2 '262026-06-30$0.00$-16.64M$-0.20$-14.53M
Q1 '262026-03-31$0.00$-22.19M$-0.32$-22.21M
Q4 '252025-12-31$0.00$-23.37M$-0.34$-17.23M
Q3 '252025-09-30$0.00$-17.75M$-0.26$-15.38M
Q2 '252025-06-30—$-52.62M$-0.76$-52.96M
Q1 '252025-03-31$7.14M$73.02M$1.83$-11.86M
Q3 2026 • period ending 2026-09-30 • filed 2026-11-09
Valuation

Ratios derived from TTM financials and the current market price, sampled daily. History chart shows how expensive the stock is today relative to its own recent past.

Price Multiples
  • P/E — price / TTM earnings. Rough market rule: 10–15 value, 15–25 market, >30 growth/premium. Negative when earnings are negative.
  • P/B — price / book value. Useful for financials and asset-heavy names; meaningless for asset-light software.
  • P/S — price / TTM revenue. Useful when earnings are negative or noisy (early-stage growth).
  • EV/EBITDA — capital-structure-neutral. <10 cheap, 10–15 reasonable, >20 rich. Good for comparing across leverage profiles.
  • EV/Sales — like P/S but accounts for debt + cash. Compare within sector.
Profitability & Yields
  • ROE — return on equity. >15% strong, >25% exceptional. Caution: high leverage inflates ROE.
  • ROA — return on assets. Leverage-neutral; >5% solid, >10% exceptional.
  • Div Yield — annual dividend / price. Compare to 10Y Treasury; sustained yield >6% often signals distress.
  • FCF Yield — free cash flow / market cap. >5% is attractive; negative means burning cash.
Balance Sheet
  • Debt/Equity — leverage. <1 conservative, >2 aggressive. Sector-dependent (utilities naturally high, tech low).
  • Current Ratio — short-term liquidity. >1.5 comfortable, <1 raises short-term solvency flags.
Reading the history chart
  • Compare current level to the 3-year band: near the high end = relatively expensive; near the low = relatively cheap.
  • Multiples expanding while earnings are flat = sentiment-driven rally.
  • Multiples compressing while earnings grow = value coming from fundamentals.
P/E
—
P/B
1.51
P/S
—
EV/EBITDA
—
EV/Sales
—
ROE
-51.1%
ROA
-48.0%
Div Yield
0.00%
FCF Yield
-29.85%
Debt/Equity
0.00
Current Ratio
—
Market Cap
$246.73M
as of 2026-11-19

WHWK vs Peers

Related companies, largest first
Company Market cap P/E Revenue growth YTD IV rank
ATRC AtriCure, Inc. $2.8B 181.4 +13.8% +38.6% 18
XNCR Xencor, Inc. $2.6B — +33.5% +127.9% 44
PCRX Pacira BioSciences, Inc. Common Stock $1.5B 39.2 +3.7% +49.1% 6
SIBN SI-BONE, Inc. Common Stock $1.1B — +14.0% +20.1% 40
CYRX CryoPort, Inc. Common Stock $1.0B — +11.8% +103.5% 37
KIDS OrthoPediatrics Corp. Common Stock $826M — +16.1% +85.2% 38
MYGN Myriad Genetics Inc $530M — −2.6% −9.4% 29
WHWK Whitehawk Therapeutics, Inc. Common Stoc $185M — — +28.3% 25
QTEX QTREX Quantum Ltd. Ordinary Shares $75M — — +183.6% —
Peer median $1.0B 110.3 +13.8% +67.2% 37

P/E uses the latest reported trailing-12-month diluted EPS; "—" means no positive earnings or no data.

Short Interest & Float

Regulatory short-interest reports publish on a bi-weekly settlement cadence; short-volume is reported daily by the trade-reporting facilities. Float is derived from insider-ownership filings.

Metric definitions
  • Short Interest — total shares currently sold short as of the settlement date. Lags real time by ~8 business days.
  • SI % of Float — short interest / free float. The key crowding metric.
  • Days to Cover — short interest / avg daily volume. How many full trading days it would take shorts to buy back. High DTC + catalyst = squeeze fuel.
  • Short Vol Ratio — today's short-sale volume / total volume. Intraday selling pressure proxy (not the same as short interest).
  • Free Float — shares available for public trading (total shares minus insider / restricted).
  • Float % — free float / shares outstanding. <50% = tightly held, more prone to squeezes.
How to read the signals
  • SI % of Float < 5% — typical, no particular signal.
  • 5–15% — elevated; watch for catalysts (earnings, guidance, macro).
  • 15–30% — heavily shorted; tight-float names in this range have produced notable squeezes historically.
  • >30% — extreme; borrow is likely expensive and squeeze risk is material.
  • Days to Cover > 5 combined with high SI% amplifies squeeze potential.
History chart
  • Trend matters more than level. Rapidly rising short interest often precedes negative catalysts or heavy hedging.
  • A sudden drop in SI after a rally may indicate a squeeze in progress.

Short interest is reported mid-month and end-of-month; short volume is daily.

Short Interest
2.49M
SI % of Float
8.27%
Days to Cover
7.81
Short Vol Ratio
59.0%
Free Float
30.07M
Float %
52.7%
Short interest 2026-10-30 • Short volume 2026-11-18 • Float 2026-08-14